-
EP1812030
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1812030
| EP1812030 - ANTI-ANGIOGENIC PEPTIDES AND METHODS OF USE THEREOF [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 19.02.2010 Database last updated on 04.11.2024 | Most recent event Tooltip | 19.02.2010 | Application deemed to be withdrawn | published on 24.03.2010 [2010/12] | Applicant(s) | For all designated states Sopherion Therapeutics, Inc. 25 Science Park at Yale 150 Munson Street New Haven, CT 06511 / US | [2007/31] | Inventor(s) | 01 /
RASTELLI, Luca 25 Science Park at Yale, 150 Munson Street New Haven, CT 06511 / US | 02 /
LANDIN, Judith 25 Science Park at Yale, 150 Munson Street New Haven, CT 06511 / US | 03 /
MALYANKAR, Uriel 25 Science Park at Yale, 150 Munson Street New Haven, CT 06511 / US | 04 /
KISTON, Richard 25 Science Park at Yale, 150 Munson Street New Haven, CT 06511 / US | 05 /
CORSO, Melissa 25 Science Park at Yale, 150 Munson Street New Haven, CT 06511 / US | 06 /
BRUNSON, Kenneth 25 Science Park at Yale, 150 Munson Street New Haven, CT 06511 / US | [2007/31] | Representative(s) | Cripps, Joanna Elizabeth, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | [N/P] |
| Former [2007/31] | Cripps, Joanna Elizabeth, et al Mewburn Ellis LLP York House 23 Kingsway London WC2B 6HP / GB | Application number, filing date | 05808477.3 | 14.10.2005 | [2007/31] | WO2005US36959 | Priority number, date | US20040618273P | 14.10.2004 Original published format: US 618273 P | [2007/31] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2006044614 | Date: | 27.04.2006 | Language: | EN | [2006/17] | Type: | A2 Application without search report | No.: | EP1812030 | Date: | 01.08.2007 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.04.2006 takes the place of the publication of the European patent application. | [2007/31] | Search report(s) | International search report - published on: | US | 10.08.2006 | (Supplementary) European search report - dispatched on: | EP | 11.12.2008 | Classification | IPC: | A61K38/00, C07K14/00 | [2009/02] | CPC: |
C07K14/475 (EP,US);
A61K47/62 (EP,US);
A61P27/02 (EP);
A61P35/04 (EP);
C07K14/001 (EP,US);
C07K7/06 (EP,US);
|
| Former IPC [2007/31] | A61K38/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/31] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | YU | Not yet paid | Title | German: | ANTI-ANGIOGENE PEPTIDE UND ANWENDUNGSVERFAHREN DAFÜR | [2007/31] | English: | ANTI-ANGIOGENIC PEPTIDES AND METHODS OF USE THEREOF | [2007/31] | French: | PEPTIDES ANTI-ANGIOGENIQUES ET PROCEDES D'UTILISATION DE CEUX-CI | [2007/31] | Entry into regional phase | 10.05.2007 | National basic fee paid | 10.05.2007 | Search fee paid | 10.05.2007 | Designation fee(s) paid | 10.05.2007 | Examination fee paid | Examination procedure | 10.05.2007 | Amendment by applicant (claims and/or description) | 10.05.2007 | Examination requested [2007/31] | 18.03.2009 | Despatch of a communication from the examining division (Time limit: M06) | 29.09.2009 | Application deemed to be withdrawn, date of legal effect [2010/12] | 04.11.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2010/12] | Fees paid | Renewal fee | 24.10.2007 | Renewal fee patent year 03 | 31.10.2008 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.10.2009 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO0183693 (GLAXO GROUP LTD [GB], et al) [Y] 1-23,36-67 * the whole document * * examples 1-47 *; | [Y]WO0234767 (ARK THERAPEUTICS LTD [GB], et al) [Y] 1-23,36-67 * the whole document * * page 6 - page 7 *; | [Y]WO2004058802 (AMERSHAM HEALTH AS [NO], et al) [Y] 1-23,36-67 * the whole document *; | [A] - TANDLE A. ET AL., "Antiangiogenic gene therapy of cancer", J. OF TRANSLATIONAL MEDECINE, (20040625), vol. 2, no. 22, pages 1 - 20, XP002505618 [A] 1-23,36-67 * the whole document * * page 6 * DOI: http://dx.doi.org/10.1186/1479-5876-2-22 | [YD] - BINETRUY-TOURNAIRE ROSELYNE ET AL, "Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis", EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, (20000403), vol. 19, no. 7, ISSN 0261-4189, pages 1525 - 1533, XP002179245 [YD] 1-23,36-67 * the whole document * DOI: http://dx.doi.org/10.1093/emboj/19.7.1525 | [Y] - EL-SHEIKH A ET AL, "A novel vascular endothelial growth factor heparin-binding domain substructure binds to glycosaminoglycans in vivo and localizes to tumor microvascular endothelium", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, (20021201), vol. 62, no. 23, ISSN 0008-5472, pages 7118 - 7123, XP002279013 [Y] 1-23,36-67 * the whole document * | [Y] - KASAI S ET AL, "Design and synthesis of antiangiogenic/heparin-binding arginine dendrimer mimicking the surface of endostatin", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (20020301), vol. 12, ISSN 0960-894X, pages 951 - 954, XP002967992 [Y] 1-23,36-67 * the whole document * DOI: http://dx.doi.org/10.1016/S0960-894X(02)00066-5 | [A] - FERRARA N ET AL, "The biology of VEGF and its receptors", NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, (20030601), vol. 9, no. 6, ISSN 1078-8956, pages 669 - 676, XP002313505 [A] 1-23,36-67 * the whole document * DOI: http://dx.doi.org/10.1038/nm0603-669 | [A] - RICARD-BLUM SYLVIE ET AL, "Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling. Role of divalent cations.", JOURNAL OF BIOLOGICAL CHEMISTRY, (20040123), vol. 279, no. 4, ISSN 0021-9258, pages 2927 - 2936 [A] 1-23,36-67 * the whole document * | [A] - KIM Y-M ET AL, "Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,; US, (20020802), vol. 277, no. 31, ISSN 0021-9258, pages 27872 - 27879, XP002959880 [A] 1-23,36-67 * the whole document * DOI: http://dx.doi.org/10.1074/jbc.M202771200 | International search | [A]US2003045498 (KOVESDI IMRE [US], et al); | [A]US2003158112 (CAMPOCHIARO PETER A [US]) |